Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer
Completed
Conditions studied: Pancreatic Cancer
In brief
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study uses gene expression profiling to compare primary tumor cells with metastatic tumor cells in patients with metastatic pancreatic cancer.
Key facts
- Study ID
- NCT00897741
- Run by
- Barbara Ann Karmanos Cancer Institute
- People needed
- 10
- Starts
- 2004-12-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2014-02-11
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.